PubRank

Kenneth R Chapman

Author PubWeight™ 45.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 2006 3.27
2 Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003 2.43
3 Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014 2.00
4 A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect 2009 1.77
5 Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med 2006 1.71
6 Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest 2010 1.49
7 The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest 2006 1.38
8 Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician 2007 1.24
9 Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med 2013 1.19
10 What do we know about asthma triggers? a review of the literature. J Asthma 2012 1.06
11 Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD 2012 1.04
12 Variations and gaps in management of acute asthma in Ontario emergency departments. Chest 2008 0.97
13 The coming of age of asthma guidelines. Lancet 2008 0.96
14 Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med 2002 0.95
15 Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J 2003 0.89
16 Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2012 0.89
17 Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One 2013 0.89
18 A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology 2012 0.88
19 Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res 2012 0.87
20 Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003 0.86
21 Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma 2006 0.85
22 Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries. J Asthma 2013 0.84
23 Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med 2009 0.84
24 Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J 2007 0.84
25 Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J 2012 0.83
26 Influence of current or former smoking on asthma management and control. Can Respir J 2008 0.83
27 Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med 2005 0.83
28 Economic issues in the use of office spirometry for lung health assessment. Can Respir J 2003 0.82
29 The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2008 0.82
30 Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ 2012 0.82
31 The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract 2007 0.82
32 Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J 2010 0.82
33 Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma 2004 0.81
34 Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003 0.81
35 Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol 2007 0.80
36 Tiotropium and simplified detection of dynamic hyperinflation. Chest 2007 0.79
37 Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med 2010 0.79
38 Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J 2011 0.78
39 Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol 2010 0.78
40 SMART isn't. J Allergy Clin Immunol 2010 0.76
41 Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. Respir Med 2009 0.76
42 A step forward in COPD management: reading between the lines. Chest 2012 0.75
43 Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J 2009 0.75
44 Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD 2015 0.75
45 Seretide: a pharmacoeconomic analysis. J Med Econ 2008 0.75
46 Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respir Med 2012 0.75
47 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. J Glaucoma 2017 0.75